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Abstract 
Catheter-directed thrombolysis (CDT) for iliofemoral deep vein thrombosis (DVT) aims at 
reducing acute leg symptoms and at preventing the incidence of the postthrombotic 
syndrome. There are no data from controlled trials in pregnant patients. Reports of 
thrombolysis treating DVT during pregnancy are scarce. Pregnancy is considered a relative 
contraindication to thrombolytic therapy because of the risk of bleeding and concerns 
about the effects of radiation exposure on the fetus. We report on a CDT procedure without 
radiation and contrast exposure in a first trimester pregnant patient with massive 
iliofemoral DVT and free-floating thrombus extending to the suprarenal inferior vena cava.   
 
Deep vein thrombosis (DVT) is a major complication that occurs in 1.36 per 1000 
pregnancies, with pulmonary embolism (PE) being a leading cause of maternal morbidity 
in developing countries (1). 
Anticoagulation therapy, the current standard of care for deep vein thrombosis, inhibits 
thrombus propagation and provides prophylaxis against pulmonary embolism (2). 
Iliofemoral DVT is associated with a high risk of post-thrombotic syndrome (PTS) (3, 4). 
Treating DVT in pregnancy with anticoagulation alone results in a high rate of post-
thrombotic morbidity and impaired quality of life in this group of young and otherwise 
healthy patients. In a study of 104 women with pregnancy-related thrombosis, only 22% 
reported freedom of postthrombotic symptoms after a median follow up time of 11 years. 
(5).  
Due to the bleeding risk of systemic lysis and the high risk of rethrombosis after surgical 
procedures, catheter-directed thrombolysis for iliofemoral DVT has been established for 
selected patients with good functional status and a low risk of bleeding (6). Administering 
rt-PA directly into the venous clot allows for a significant dose reduction compared to 
systemic thrombolysis (7).  
In one randomized trial, CDT improved clinically relevant long-term outcome after 
iliofemoral DVT by reducing PTS compared to conventional treatment with 
anticoagulation and compression stockings alone (7). In another trial (ATTRACT), the 
incidence of the PTS was not reduced by CDT, most likely because almost half of the 
patients had proximal DVT without involvement of the iliac veins (8). 
There are concerns about the effects of radiation exposure on proliferating maternal breast 
tissue and on the fetus during pregnancy, particularly during organogenesis in the first 
trimester. We report on a CDT procedure without radiation and contrast exposure in a first 
trimester pregnant patient with massive thrombus extending from the proximal part of the 
left common femoral vein to the suprarenal inferior vena cava without involvement of the 
renal veins.  
The patient provided written informed consent to the publication. 
 
Case report 
A 29-year-old woman at 11 2/7 weeks of gestation was referred to our clinic due to sudden 
massive, painful swelling of the left lower extremity with inability to walk. Ultrasound 
revealed a complete obstruction of the left common femoral and iliac veins with extension 
of a free-floating thrombus into the suprarenal inferior vena cava (IVC) (Fig. 1).  
On admission, an intravenous bolus of 5,000 I.U. of unfractionated heparine (UFH) was 
given, followed by continuous intravenous infusion of UFH, adjusted to maintain an 
activated partial thromboplastine time (aPTT) between 46 and 70 sec.  
The hypercoagulability evaluation was negative for antiphospholipid antibody syndrome, 
factor V-Leiden-mutation and prothrombin gene variant. Protein C, protein S, and 
antithrombin-III levels were normal.  
After 24 hours of heparin treatment, no improvement of the clinical status was seen. Serial 
ultrasound examination revealed persistence of the free-floating suprarenal IVC thrombus. 
Implantation of an inferior vena cava filter was deemed technically not feasible because of 
the close proximity of the thrombus to the right atrium.  
To avoid a fatal pulmonary embolism and to reduce acute leg symptoms we decided to 
perform catheter-directed thrombolysis, inserting the thrombolysis-catheter under 
ultrasound guidance to avoid radiation and contrast exposure. We preferred CDT over 
pharmacomechanical thrombectomy to minimize the risk of embolization of the free-
floating IVC thrombus with mechanical maneuvers. 
The insertion of the thrombolysis catheter was performed with heart surgery stand by. 
Venous access was obtained in the non-obstructed femoral vein at the proximal thigh by 
ultrasound guidance with the patient in supine position. After insertion of a 6-F sheath, a 
0.035 inch hydrophilic guidewire (Terumo Corporation, Tokyo, Japan) and a standard 
angiographic 4-F diagnostic catheter (Berenstein, Cordis, Milpatis, CA) were used to pass 
the thrombus. Ultrasound guidance was performed with B-mode ultrasound using a 6 
MHz sector ultrasound probe tracking the inserted catheter material in the iliofemoral 
veins and inferior vena cava using longitudinal and transverse views (Fig. 2). The 
angiographic catheter was then exchanged for the drug delivery catheter with a 30 cm 
treatment zone corresponding to the length of the thrombotic occlusion (EKOS 
Corporation; Bothell, WA). Finally the guidewire was replaced by the MicroSonic Device 
(MSD, EKOS Corporation; Bothell, WA) that contains multiple small, radiopaque 
ultrasound transducers distributed along the treatment zone to deliver high-frequency (2.2 
MHz) and low-power (0.5 Watt per transducer) ultrasound.  
After introduction of the thrombolysis catheter the patient was transferred to the 
intermediate care unit and the thrombolysis infusion was started with rt-PA (Actilyse, 
Boehringer Ingelheim, Ingelheim, Germany) at a rate of 2mg/h for the first 5 hours, then 
reduced to 1mg/h over 10 hours. Unfractionated heparin infusion was administered and 
adjusted every 6 hours to achieve and maintain an aPTT corresponding to therapeutic 
heparin levels. 
Intermittent pneumatic compression of the whole left leg was used to enhance the 
thrombolysis success.  
After 15h of treatment, ultrasound confirmed complete thrombus resolution in the left 
iliofemoral vein as well as in the inferior vena cava (Fig. 3).  
After restoration of blood flow in the iliac veins, presence of a May Thurner syndrome 
was confirmed (Fig. 4).   
Anticoagulation with intravenous heparin was switched to low-molecular heparin 
(LMWH) subcutaneously. An obstetric exam with ultrasound confirmed normal vital 
gestation and the patient was discharged the same day. 
At 37 5/7 week of gestation, the patient delivered a healthy boy by caesarian section. 
Three month after delivery, the patient was scheduld for the stent placement procedure. A 
venography and IVUS confirmed the presence of a compressed left common iliac vein 
which was treated by placing an oblique hybrid stent (Sinus Obliquus 16x100 mm, 
Optimed, Germany).  
Discussion 
We report on a CDT procedure without radiation and contrast medium exposure in a first-
trimester pregnant patient with massive iliofemoral DVT and free-floating thrombus 
extending to the suprarenal inferior vena cava. Our patient had no evidence of 
thrombophilia and the reason for her extensive DVT was most likely ascending and 
descending thrombus propagation from the compressed left common iliac vein (May 
Thurner syndrome). The main reason for the choosen treatment was to prevent fatal 
pulmonary embolism of the large IVC thrombus. Placement of an IVC filter would have 
been an option if the suprarenal IVC were free of thrombus. Following successful 
thrombolysis, we postponed stent placement to completion of the postpartum period to 
avoid radiation and contrast exposure. We believe that percutaneous B-mode ultrasound 
guidance is not precise enough to accurately detect stent landing zones in the iliac veins. 
The second principal reason for our invasive approach was the prevention of post-
thrombotic morbidity. DVT is a common pregnancy-related complication, with significant 
morbidity and risk of PTS in patients with iliofemoral DVT. Most cases occur in the 
second and third trimester. Iliofemoral DVT in the first trimester is rather unusual. Most 
physicians and guidelines recommend treating pregnancy-related iliofemoral DVT with 
anticoagulation alone (6).  In treating iliofemoral thrombosis, CDT techniques have 
demonstrated good results in the non-pregnant population (7,9,10,11,12). The main 
advantage of a catheter-based approach is to increase venous patency and preserve venous 
valve function, with minimal risk of bleeding complications, and to provide endovascular 
access for adjunctive therapeutic techniques such as balloon angioplasty and stent 
placement (13). 
The first report of successful use of CDT in pregnancy was published in 1999, describing 
three mid-gestation patients, one with massive pulmonary embolism and two patients with 
extensive proximal DVT. Thrombolytic therapy provided rapid resolution of symptoms 
and no adverse fetal outcomes were observed (14).  
A report of 11 pregnant patients undergoing CDT and/or pharmacomechanical catheter-
directed thrombolysis (PCDT) is the largest series to date (15). This study suggested a 
good safety profile with excellent short- and midterm results. However, the authors did 
not address the potential risks to the fetus associated with the radiation exposure. 
Radiation exposure in the first trimester may cause fetal death (16, 17). The fetal radiation 
dose resulting from catheter-directed thrombolysis in the first trimester can be calculated 
in the range of 175-245 mGy, which is associated with a childhood cancer risk of 1.3%-
2%. This value is 6 to 10 times higher than the risk associated with 
environmental/background radiation exposure (18).   
Because of the potential risks of the fetal radiation exposure another case report described 
elective termination of pregnancies following CDT in the first trimester (18). This 
approach was however not acceptable for our patient. 
Conclusion 
Iliofemoral DVT in pregnant women raises a unique therapeutic challenge. In our case, we 
performed a successful CDT procedure in a pregnant woman in the first trimester without 
complications. To prevent radiation exposure the placement of the lysis catheter was 
realized with ultrasound guidance. Further trial or registry experience is needed to 
demonstrate the efficacy and safety of this therapeutic approach. 
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The patient provided written informed consent to the publication. 
Fig. 1 Free-floating thrombus in the suprarenal inferior vena cava (arrow, longitudinal view) 
 
Fig. 2 Ultrasound guidance while advancing the catheter material through the thrombotic 
occlusion of the iliocaval veins (arrow: tip of 5 French EKOS catheter in suprarenal inferior 
vena cava, longitudinal view) 
Fig. 3 Suprarenal  inferior vena cava after CDT with complete thrombolysis success 
(longitudinal view) 
 
Fig. 4 Compression of the left common iliac vein by the right common iliac artery (arrow) 
 
 
 
 
 
 
